FDA Issues More Warnings For Statins
The Food and Drug Administration has issued a second warning regarding the use of statin medications in a matter of days. The second warning is in regards to interactions the cholesterol lowering drugs may have when taken with HIV or Hepatitis C drugs.
Myopathy in its most serious form, rhabdomyolysis, can damage a patient’s kidneys and lead to kidney failure, which can lead to death.
The labels on HIV drugs and affected statins have been updated with the new information about the adverse risks that may occur from the drug interactions.
Recent studies have shown that statins may increase the risk of diabetesfor patients.